[Immunotherapy with anti-SARS-COV-2 neutralizing F(ab')2 antibodies from equine serum in the treatment of outpatients with bilateral COVID-19 pneumonia].
Medicina(2022)
摘要
Although the rate of hospitalization and death were lower than expected, the use of hyperimmune equine serum in the outpatient setting impresses as not providing clinical benefit.
更多查看译文
关键词
equine hyperimmune serum,immunotherapy,pneumonia COVID-19
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要